PMID- 23391323 OWN - NLM STAT- MEDLINE DCOM- 20130709 LR - 20211021 IS - 2050-6511 (Electronic) IS - 2050-6511 (Linking) VI - 14 DP - 2013 Feb 8 TI - Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units. PG - 10 LID - 10.1186/2050-6511-14-10 [doi] AB - BACKGROUND: Antipsychotic drugs are widely used for the treatment of Behavioral and Psychological Symptoms of Dementia (BPSD), despite their limited efficacy and concerns about safety. The aim of this study was to describe antipsychotic drug therapy among people with dementia living in specialized care units in northern Sweden. METHODS: This study was conducted in 40 specialized care units in northern Sweden, with a total study population of 344 people with dementia. The study population was described in regard to antipsychotic drug use, ADL function, cognitive function and BPSD, using the Multi-Dimensional Dementia Assessment Scale (MDDAS). These data were collected at baseline and six months later. Detailed data about antipsychotic prescribing were collected from prescription records. RESULTS: This study showed that 132 persons (38%) in the study population used antipsychotic drugs at the start of the study. Of these, 52/132 (39%) had prescriptions that followed national guidelines with regard to dose and substance.After six months, there were 111 of 132 persons left because of deaths and dropouts. Of these 111 people, 80 (72%) were still being treated with antipsychotics, 63/111 (57%) with the same dose. People who exhibited aggressive behavior (OR: 1.980, CI: 1.515-2.588), or passiveness (OR: 1.548, CI: 1.150-2.083), or had mild cognitive impairment (OR: 2.284 CI: 1.046-4.988), were at increased risk of being prescribed antipsychotics. CONCLUSION: The prevalence of antipsychotic drug use among people with dementia living in specialized care units was high and inappropriate long-term use of antipsychotic drugs was common. FAU - Gustafsson, Maria AU - Gustafsson M AD - Maria Gustafsson, Department of Pharmacology and Clinical Neuroscience, Umea University, 901 85, Umea, Sweden. maria.gustafsson@pharm.umu.se FAU - Karlsson, Stig AU - Karlsson S FAU - Lovheim, Hugo AU - Lovheim H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130208 PL - England TA - BMC Pharmacol Toxicol JT - BMC pharmacology & toxicology JID - 101590449 RN - 0 (Antipsychotic Agents) SB - IM MH - Aged MH - Aged, 80 and over MH - Antipsychotic Agents/*therapeutic use MH - Dementia/*drug therapy MH - Drug Utilization Review/*statistics & numerical data MH - Female MH - Humans MH - Male MH - Nursing Homes/statistics & numerical data MH - Sweden PMC - PMC3575309 EDAT- 2013/02/09 06:00 MHDA- 2013/07/10 06:00 PMCR- 2013/02/08 CRDT- 2013/02/09 06:00 PHST- 2012/09/17 00:00 [received] PHST- 2013/02/04 00:00 [accepted] PHST- 2013/02/09 06:00 [entrez] PHST- 2013/02/09 06:00 [pubmed] PHST- 2013/07/10 06:00 [medline] PHST- 2013/02/08 00:00 [pmc-release] AID - 2050-6511-14-10 [pii] AID - 10.1186/2050-6511-14-10 [doi] PST - epublish SO - BMC Pharmacol Toxicol. 2013 Feb 8;14:10. doi: 10.1186/2050-6511-14-10.